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Abstract The role of the gut microbiota in the induction
of metabolic diseases has now been increasingly recog-
nized worldwide. Indeed, a specific gut microbiota has
been shown to characterize lean versus obese phenotypes
both in humans and mice. We have also recently demon-
strated that a precise gut microbiota is associated with the
host’s responsiveness to a high-fat diet. Therefore, we
hypothesized that insulin resistance in humans could also
be linked to a specific gut microbiota. To this aim,
microbial DNA and RNA were extracted from the appen-
dix contents of insulin-resistant versus insulin-sensitive
obese subjects, matched for body mass index and age, and
analyzed by DNA- and RNA-DGGE. Microbial DNA
analysis showed that the patients fully segregated accord-
ing to their degree of insulin action. Conversely, microbial
RNA investigation showed that some degree of homology
still existed between insulin-sensitive and insulin-resistant
patients. Quantitative trait analysis, ordinary least squares
regression, principal components regression, partial least
squares, canonical correlation analysis, and canonical cor-
respondence analysis also showed a net separation of the
two phenotypes analyzed. We conclude that a specific gut
microbial profile is associated with insulin action in
humans.
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Introduction
Metabolic diseases such as obesity and type 2 diabetes are
characterized by alterations in energy balance which
explains, at least in part, the occurrence of obesity. On one
hand, the impact of genetic trait variants accounts for only
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up to 10 % [1] of the excessive body weight gain [2]. On
the other hand, environmental factors such as stress, a
sedentary lifestyle, and nutrition habit, although impor-
tant, cannot explain the left-over 90 % of the pandemic
progression of metabolic impairment. A recent hypothesis
suggests that human beings can be considered as ‘‘super-
organisms’’ as a result of their symbiotic association with
the gut microbiota [3]. Recent data demonstrated that the
profile of genes expressed by the intestinal microbiota—
the gut microbiome—varies between healthy [4, 5] and
even between lean and obese individuals and was con-
sidered as a specific signature of the metabolic phenotype
[5]. Similarly, obese mice deleted for the leptin gene were
characterized by a change in the Bacteroidetes to Firmi-
cutes ratio, the major phyla present in the intestinal
microbiota of humans [5] and mice [6]. With regard to the
role of environmental factor, we and others showed the
major role of a fat-enriched diet on the change in intes-
tinal microbiota. We first identified lipopolysaccharides
(LPS) from gram negative bacteria as the molecular link
between gut microbiota and the chronic low-grade
inflammatory tone [7, 8] induced by a high-fat diet [7, 8]
that leads to insulin resistance. Hence, LPS could be
considered as an initiator of metabolic diseases [9].
Altogether, gut microbiota unbalance is now considered
as an important trigger of white adipose tissue (WAT)
plasticity, regulating fat-storage [10], energy-harvesting
[11], diet-induced obesity [12], and adiposity [13]. How-
ever, the relationship between gut microbiota and insulin
action in human obesity has never been established. To
this aim, we evaluated the diversity of microbial cecal
(appendix) DNA and RNA in insulin-resistant versus
insulin-sensitive obese subjects.
Results
Gut DNA microbial profiles identify clusters of patients
according to insulin action
To determine whether a DNA-based gut microbial profile
may be associated with insulin action, we performed a
DNA-DGGE on the cecum (appendix) contents from 8
insulin-resistant (IR) and 8 insulin-sensitive (IS) subjects
(all obese; 7 women and 1 man in both groups) comparable
in age and body mass index (BMI). Notably, DNA-DGGE
profiles (Fig. 1a) fully segregated according to insulin-
sensitive (IS) or insulin-resistant (IR) phenotypes, as shown
in Fig. 1b by the evolutionary analysis based on Pearson’s
tree method. Intra-group homology was higher than inter-
group homology. In detail, gut microbial profiles from both
groups of patients were characterized by a specific pattern
of electrophoresis bands (Fig. 1a), hereafter referred to as
microbial markers. In fact, the IR versus IS phenotypes
shared only 4 microbial markers (8 and 7 % out of the total
for IR and IS, respectively), as shown by the Venn’s dia-
gram in Fig. 2a. Therefore, 92 and 93 % of the DNA-based
gut microbial profile was specific for the IR and IS phe-
notypes, respectively.
Next, the intensity of each microbial marker was con-
verted into a heat-map. A Pearson’s tree evolutionary
analysis allowed clusters of microbial markers to be iden-
tified which specifically belonged to a given phenotype
(Fig. 2b, left-side).
We further used the Quantitative Trait Analysis, the
Ordinary Least Squares regression (OLS), Principal Com-
ponents Regression (PCR), Partial Least Squares (PLS),
Canonical Correlation Analysis (CCA), and Canonical
Fig. 1 DNA gut microbial profile from the ceca of insulin-sensitive
and insulin-resistant obese patients. Total DNA from both luminal
and mucosal cecum (appendix) was extracted from obese insulin-
resistant and obese insulin-sensitive patients. The 16S rDNA was
amplified, and the amplicons were separated by electrophoresis on a
gel with a denaturating gradient (DGGE). Each band was referred to
as a microbial marker. The figure shows a the DNA-DGGE gel, with
an internal marker (M) for electrophoresis control and b the cluster
analysis showing the Pearson’s evolutionary tree (left-side)
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Correspondence Analysis (CAnoCO). Characteristic mark-
ers were obtained by selecting those variables retained in
regression models such as OLS, PLS, and PCR or by
selecting those variables that appeared associated with
differences in IR versus IS when representing the data in
reduced dimension after CCA or CANOCO. For OLS, 4
variables were retained after stepwise selection. PCR and
PLS were applied without previous selection of variables,
and 4 variables were retained by PCR and 9 by PLS. CCA
and CANOCO were performed without any previous var-
iable selection. Ten variables were retained by CCA and
CANOCO. Combining all these methods, we found 3 DNA
microbial markers (86.8 and 103.8 from IS patients; 136.4
from IR patients; numbers refer to the relative migration
within the electrophoresis gel) highlighted by all methods,
showing an association with insulin resistance (HOMA
value) (Table 1). Moreover, 3 additional DNA microbial
markers (43.4, 92.5, 96.2, all from IS patients) were
highlighted by at least three approaches (Table 1).
Gut RNA microbial profile varies in accordance
with insulin action
To investigate whether the high level (greater than 91 %)
of segregation of gut DNA microbial profiles observed in
IR versus IS patients may be associated with a differential
encoding activity of gut microbes, we performed a RNA-
DGGE on the same samples analyzed above. Conversely
to what observed on DNA-DGGE, RNA-DGGE gut
microbial profiles (Fig. 3a) still showed a certain degree
of homology between the IR versus IS patients. In fact,
the evolutionary analysis based on Pearson’s tree method
showed a subgroup of patient according to the IR or
IS phenotype (Fig. 3b). Interestingly, IS patients were
Fig. 2 Comparative analysis of microbial markers from the DNA gut
microbial profile of insulin-sensitive and insulin-resistant obese
patients. a Venn’s diagram comparing DNA gut microbial markers
and b heat-map based on microbial marker intensity. Pearson’s tree
evolutionary analysis has been conducted with regard to marker
segregation according to the clinical phenotype (IR vs. IS, top and
left-side of the heat-map)
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characterized by a higher degree of homology than IR
(Fig. 3b, left-side).
In detail, the IR versus IS phenotypes shared 38 micro-
bial markers (65 and 84 % out of the total for IR and IS,
respectively), as shown by the Venn’s diagram reported in
Fig. 4a. Therefore, 35 and 16 % of the RNA-based gut
microbial profile was specific for IR and IS phenotypes,
respectively. In accordance with this result, the heat-map
Table 1 Associative analysis
between DNA microbial









PIS CCA # of
highlights
43.4 1 X X 3
47.2 X 1
50.9 1 1
67.3 X X 2
76.4 X 1
77.4 X 1
86.8 4 X X X X X 6
92.5 1 X X 3
92.7 X 1
96.2 1 X X 3
100 2 1
103.8 7 X X X X X 6




136.4 5 X X X X X 6
141.5 X 1
150.9 3 X 2
162.3 X 1
170.9 X 1
Fig. 3 RNA gut microbial profile from ceca of insulin-sensitive and
insulin-resistant obese patients. Total RNA from both luminal and
mucosal cecum (appendix) was extracted from obese insulin-resistant
and obese insulin-sensitive patients. The 16S rRNA was retrotran-
scripted, then cDNA amplified, and the amplicons were separated by
electrophoresis on a gel with a denaturating gradient (DGGE). Each
band was referred to as a microbial marker. The figure shows a the
RNA-DGGE gel, with an internal marker (M) for electrophoresis
control and b the cluster analysis showing the Pearson’s evolutionary
tree (left-side)
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based on RNA microbial markers and the corresponding
Pearson’s evolutionary analysis (Fig. 4b, left-side) showed
clusters of segregation to a lesser extent than DNA-DGGE
analysis.
Discussion
We here report for the first time that insulin action in
humans fully segregates with gut microbiota issued from
the intestine, a result not yet reported from feces. This
original observation suggests first a regulatory role of the
microbiota which is directly in contact with intestinal cells
and hence the rest of the body and second that biomarkers
for the diagnosis of insulin resistance could be identified
from intestinal bacterial DNA.
The role of intestinal microbiota could be due to a
mechanism called bacterial translocation. It corresponds
to the passage of gut indigenous bacteria through the
intestinal mucosa to mesenteric lymph nodes and, in human
appendix, was found to be instrumental for tolerance
induction towards indigenous flora and the stimulation and
normal development of the gastrointestinal-associated
lymphoid tissue [14]. Substantial amounts of immune tis-
sue associated with the appendix strongly suggest immune
function capability from this gut portion.
The association of cecal appendix with substantial
amount of immune tissue was considered as an indicator
that the appendix may have some immune function.
Recently, an improved understanding of the interactions
between the normal gut flora and the immune system has
led to the identification of the appendix as an apparent safe-
house for normal gut bacteria. In fact, cladistic analyses,
indicating that the appendix has evolved independently at
least twice (once in diprotodont marsupials and once in
Euarchontoglires), show a highly significant (P \ 0.0001)
phylogenetic signal in its distribution, and has been
maintained in mammalian evolution for 80 millions years
Fig. 4 Comparative analysis of microbial markers from the RNA gut
microbial profile of insulin-sensitive and insulin-resistant obese
patients. a Venn’s diagram comparing RNA gut microbial markers
and b heat-map based on microbial marker intensity. Pearson’s tree
evolutionary analysis has been conducted with regard to marker
segregation according to the clinical phenotype (IR vs. IS, top and
left-side of the heat-map)
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or longer [15]. To present, studies on gut microbiota are
mostly based on fecal matter analysis [5, 16, 17]. Con-
versely, the aforementioned arguments strongly suggest the
importance to focus on appendix microbiota as a novel
actor capable to modulate host metabolism via shaping
appendix immune function.
We show that a core microbiome based on gene, rather
than taxon level, can be correlated with indexes of insulin
resistance. Our results are in accordance with the concept
of core microbiome identified in twin’s studies [16],
introducing the notion that different phenotypes, that are
lean versus obese, may display different patterns of gut
microbes lineages nonetheless sharing a core of functions.
However, it is noteworthy that further analyses based on
Omics techniques [18] may allow to name the gut microbes
associated with insulin resistance, providing a gut micro-
bial signature for this phenotype, to be associated with the
bacterial signature of obesity, already recognized in the
increased Firmicutes to Bacteroidetes ratio, both in humans
[5] and in mice [6].
This new concept certainly draws the route for new
discoveries regarding markers of clinical phenotypes and
regulatory factors of host metabolism. We recently showed
that bacterial DNA, mostly issued from the Proteobacteria
phylum, was found in the human blood. Importantly, the
amount of 16S rDNA was considered as a predictive
marker of the patients intended to become type 2 diabetic
6–9 years later [19]. Although the importance of the gut
microbiome for host health is now widely recognized [20–
22], it is not yet known which of the many hundreds of
species are key for host health, and little is understood
about the molecular host–microbiome interactions that
influence host metabolic pathways. Each person’s gut
microbial community varies in the specific bacterial lin-
eages, with a comparable degree of co-variation between
adult monozygotic and dizygotic twin pairs [16]. The ori-
gin of such variation is unknown but could be related to a
given phenotypic trait [23]. In fact, a specific gut microbial
profile may be responsible for a given phenotype and hence
represent a target for the development of new therapy,
based on the developing concept of personalized medicine
[3, 24].
With that regard, we have recently showed that a spe-
cific gut microbiota is associated with a given metabolic
phenotype during the phenomenon of metabolic adaptation
to a high-fat diet (HFD) in mice [25]. In fact, by pyrose-
quencing the gut microbes issued from mice fed the same
HFD and having the same genetic background, we have
shown that a different Firmicutes to Bacteroidetes ratio
signs the lean diabetic-sensitive versus lean diabetic-
resistant metabolic phenotypes.
Therefore, our results, together with the herein presented
study, corroborate the hypothesis that gut microbiota may
address host responsiveness towards a given phenotype and
that deviations from a core microbiome may lead to a
different patho-physiologic status, that is, insulin sensitiv-
ity versus insulin resistance. A previous discovery from our
laboratory showed that the blood concentration of LPS was
increased in patient feeding a fat-enriched diet, whereas no
difference was observed in those feeding on a carbohydrate
or protein-rich diet [26]. However, no correlation was
made with obesity suggesting that LPS cannot be consid-
ered as biomarker of obesity. Therefore, other factors need
to be identified. In fact, insulin resistance has been found to
be linked to several antimicrobial proteins that sense LPS
in human plasma [27, 28], suggesting that the immune
system builds specific barriers that shape our microbiota
and metabolic efficiency simultaneously [29, 30].
In conclusion, we here demonstrate that intestinal bac-
terial DNA is a signature of insulin action in humans.
Whether it has a role in the triggering or regulation of
insulin resistance still needs to be determined.
Research design and methods
Cecum intestine (appendix) from 8 insulin-resistant obese
subjects and 8 insulin-sensitive obese subjects (7 women
and 1 man in both groups) comparable in age and BMI
(Table 2) were obtained from visceral depots during elec-
tive surgical procedures (cholecystectomy, surgery for
abdominal hernia, and gastric bypass surgery). The samples
were washed, fragmented, and snap-frozen in liquid
nitrogen before being stored at -808 C. The subjects were
invited to participate at the Endocrinology Service of the
Hospital Virgen de la Victoria de Ma´laga (Ma´laga, Spain).
All subjects were of Caucasian origin with no systemic
disease other than type 2 diabetes or obesity, and all were
infection-free during the previous month before the study.
Liver disease and thyroid dysfunction were specifically
excluded by biochemical work-up. Other exclusion criteria
for the patients included the following: (1) clinically sig-
nificant hepatic, neurological, or other major systemic
disease, including malignancy; (2) history or current clin-
ical evidence of hemochromatosis; (3) history of drug or
alcohol abuse, defined as [ 80 g/day, or serum transami-
nase activity more than twice the upper limit of normal; (4)
an elevated serum creatinine concentration; (5) an acute
major cardiovascular event in the previous 6 months; (6)
acute illnesses and current evidence of acute or chronic
inflammatory or infective diseases; and (7) mental illness
rendering the subjects unable to understand the nature,
scope, and possible consequences of the study. All subjects
gave written informed consent after the purpose of the
study was explained to them. The local board of the Hos-
pital and the Ethics Committee approved the protocol.
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Anthropometric measurements
The BMI was calculated as weight (in kilograms) divided
by height (in meters) squared. The subjects’ waist was
measured with a soft tape midway between the lowest rib
and the iliac crest. The hip circumference was measured at
the widest part of the gluteus region and the waist-to-hip
ratio (WHR) calculated.
Blood pressure was measured in the supine position on
the right arm after a 10-min rest; a standard sphygmoma-
nometer of appropriate cuff size was used, and the first and
fifth phases were recorded. Values used in the analysis are
the average of three readings taken at 5-min intervals.
Patients were requested to withhold alcohol and caffeine
for at least 12 h prior to the insulin-sensitivity test.
Analytical determinations
Serum glucose levels were measured in duplicate by the
glucose oxidase method with a Beckman Glucose Analyzer 2
(Brea, CA). The coefficient of variation (CV) was 1.9 %.
Serum insulin levels were measured in duplicate by mono-
clonal immunoradiometric assay (IRMA; Medgenix Diag-
nostics, Fleunes, Belgium). The lowest limit of detection was
4.0 mU/l. The intra-assay CV was 5.2 % at a concentration of
10 mU/l and 3.4 % at 130 mU/l. The inter-assay CVs were
6.9 and 4.5 % at 14 and 89 mU/l, respectively. Frequently
sampled intravenous glucose tolerance test with minimal
model analysis was performed as previously described [30].
Total serum cholesterol was measured through the reac-
tion of cholesterol esterase/oxidase/peroxidase, using a BM/
Hitachi 747. HDL cholesterol was quantified after precipi-
tation with polyethylene glycol at room temperature. Total
serum triglycerides were measured through the reaction of
glycerol-phosphate-oxidase and peroxidase. Insulin sensi-
tivity was measured using the frequently sampled intrave-
nous glucose tolerance test with minimal model analysis, as
previously described [31].
DNA/RNA Denaturant Gradient Gel Electrophoresis
(DGGE)
Total DNA/RNA were extracted from snap-frozen cecum
contents using the TriPure reagent according to manufac-
turer’s protocol, modified by adding a bead (B 106 lm
diameter)-beating step (6,500 rpm, 3 9 30 s). Then, 200 ng
of DNA was amplified by PCR using a Taq Polymerase
(Sigma Aldrich, St. Louis, MO) and 300 nM DGGE-specific
16S rRNA universal primers (forward primer 50-CGC CCG
GGG CGC GCC CCG GGC GGG GCG GGG GCA CGG
GGG GAC TCC TAC GGG AGG CAG CAG T-30; reverse
primer 50-GTA TTA CCG CGG CTG CTG GCA C-30),
carrying (forward primer only) a GC-enriched region (GC-
clamp), generating 233-bp amplicons. The size of the latter
was verified by 2 % agarose gel electrophoresis. Then,
80 ng of amplicons was loaded onto 8 % acrylamide gel
with a 35–55 % (w/v) urea-denaturant gradient. The gels
were run overnight in TAE 1 9 , at 60 C. The following
Table 2 Anthropometrical and
biochemical variables of
subjects in the study
Insulin-sensitive subjects Insulin-resistant subjects P value
N 7 women/1 man 7 women/1 man
Age (years) 46.28 ± 12.64 43.12 ± 8.79 0.5
BMI (kg/m2) 55.8 ± 6.2 54.42 ± 5.2 0.6
WHR 0.87 ± 0.06 0.85 ± 0.08 0.6
SBP (mmHg) 141 6 ± 21.7 141 ± 15.9 0.9
DBP (mmHg) 87.1 ± 7.4 80 ± 7.9 0.15
Total cholesterol (mg/dl) 214.6 ± 40.8 208.7 ± 19.79 0.7
HDL cholesterol (mg/dl) 46.6 ± 9.7 50.42 ± 14.5 0.5
LDL cholesterol (mg/dl) 137.9 ± 23.4 126.6 ± 19.2 0.3
Fasting triglycerides (mg/dl) 94.12 ± 27.6 176.5 ± 82.2 0.02
Free fatty acids (mmol/l) 0.35 ± 0.16 0.59 ± 0.10 0.005
Insulin (mg/dl) 15.6 ± 4.1 53.9 ± 8.1 \0.0001
Glucose (mg/dl) 95.87 ± 9.6 122.37 ± 23.4 0.01
HOMA-IR 3.7 ± 1.04 16.2 ± 3.9 \0.0001
GGT (U/l) 93.14 ± 97.2 76.1 ± 81.08 0.7
GOT (U/l) 32.2 ± 34.02 26.7 ± 12.2 0.6
GPT (U/l) 73 28 ± 82 9 54.37 ± 15.2 0.5
Uric acid (mg/dl) 6.01 ± 1.1 6.17 ± 1.4 0.8
Adiponectin (ug/ml) 11.87 ± 4.02 7.2 ± 2.3 0.02
Leptin (ng/ml) 147.8 ± 105.1 136.6 ± 56.3 0.7
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day, the gels were stained for 30 min in TAE 1X-SYBR safe
DNA gel staining and scanned with a Typhoon 9400
instrument (Amersham Biosciences). The band profile was
analyzed by the PermutMatrixEN software version 1.9.3.0
[32]. One microgram of total RNA was retrotranscripted
for 2 h at 37 C using the High-Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, Villebon-sur-
Yvette, France). Ten nanograms of cDNA were amplified
using both sense and antisense primers at a concentration of
300 nM.
DGGE band analysis and Venn’s diagram
DGGE bands were identified and analyzed by using the
software ImageQuantTL (GE Healthcare Life Sciences).
Manual lane creation option was used to draw samples
lane. Then, Edit single lane option was used to adjust lane
width. Background subtraction was used to denoise
intensity values. Finally, automatic detection was applied
to identify bands. Venn diagram was constructed based on
Oliveros JC website (http://bioinfogp.cnb.csic.es/tools/
venny/index.html). No threshold was applied for band
intensity, since the background was already subtracted in
Venn’s diagrams. Therefore, all bands were analyzed for
both DNA (Fig. 2a) and RNA (Fig. 4a).
Association analysis between DNA bands
and insulin resistance
The analysis of the association between DNA bands obtained
by DGGE and clinical covariates describing individual
characteristics has been performed using multiple statistical
techniques whose results have been integrated in order to
highlight different relations obtained from diverse approa-
ches. The reason for using this integrative approach is on the
one hand because of the small number of individuals (sug-
gesting lack of power) and on the other hand because of the
ill-conditioning derived from the number of zeros (suggesting
that some approaches may be weaker than usual). Combining
different methods allows a more robust approach. Associa-
tions appearing in most analyses can be more reliably trusted
while those appearing only once can be considered as
‘‘potential’’ relations.
Two types of statistical methods were used to detect
bands that could be associated with difference between
insulin resistance and insulin sensitivity. By one side, this
relation was analyzed through variable HOMA_IR that is
clearly associated with this difference. Letting HOMA_IR
and insulin sensitivity be the response variables, the relation
was modeled through different approaches: quantitative
trait analysis to establish correlation between this variable
and each band’s values separately, and different regres-
sion methods such as Ordinary Least Squares, Principal
Components Regression, and Partial Least Squares to find a
set of explanatory variables (band) for HOMA_IR. By the
other side, multivariate analyses such as Canonical Corre-
spondence Analyses were used to find a set of variables best
correlated with the difference between IR and IS accounting
for more variables than HOMA_IR.
All analyses were performed using all variables excep-
ted for Quantitative Trait Analysis that was performed on a
one-to-one basis and OLS for which a preselection based
on significance was done.
A brief description of the statistical methods applied
follows below:
• Quantitative Trait Analysis (‘‘QTA’’ [33]) consists of
computing Spearman correlation coefficient between
band values and quantitative covariates such as
HOMA_IR. Significance is obtained by random per-
mutation testing.
• Linear regression (‘‘OLS’’, [34]) has been performed
taking HOMA_IR and insulin sensitivity as the dependent
variables and bands showing a significant difference
between IR and IS patients as explanatory variables.
Stepwise regression was used to retain a set of most
explanatory bands in the model. The variables were
filtered for OLS to have as many variables as individuals.
• Principal Components Regression (‘‘PCR’’, [34]) was
done by first performing a Principal Components Anal-
ysis on all bands, which yield a new set of independent
‘‘eigen-bands’’, then performing a linear regression,
including stepwise variable selection and finally reverting
the model to the original scale yielding a coefficient for
each band which was used to select bands positively or
negatively associated with the response variable.
• Partial least squares (‘‘PLS’’, [35]) can be seen as a
technique related to Principal Components Regression
but which fits a linear regression model by projecting
the predicted variables and the observable variables to a
new space where the relation between the variables can
be better visualized.
• Canonical Correlation Analysis (‘‘CCA’’, [36]) is a
multivariate method to find correlation between sets of
variables. It was performed between a subset of bands
obtained by clustering and selecting one canonical
representative per cluster and a subset of quantitative
clinical variables. An extra regularization step was
applied to account for the problem of having more
bands than individuals.
• Canonical Correspondence Analysis (‘‘CANOCO’’, [37])
is a method developed in Ecology that builds on
Correspondence analysis, a multivariate method applica-
ble to analyze cross-tables such as those formed by bands
and patients to allow the incorporation of extra explan-
atory variables in the analysis (here clinical variables).
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